Clincosm LogoSign in Get a demo

Non-Hodgkin's Lymphoma

Showing NaN - NaN of 33
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma Trial in Australia, Germany, United States

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • Duarte, California
  • +16 more
Dec 3, 2021

Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma Trial in Canada, United States (ABT-263)

Completed
  • Chronic Lymphoid Leukemia
  • +5 more
  • Los Angeles, California
  • +11 more
Jul 28, 2021

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in Worldwide (HCD122)

Completed
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Lymphoma
  • Chicago, Illinois
  • +27 more
Dec 11, 2020

Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

Completed
  • Related Donors Donating PBSC to a Family Member
  • +7 more
  • Tampa, Florida
  • +11 more
Sep 3, 2020

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Infusion of one MPC expanded cord unit and one unexpanded cord unit
  • Infusion of two unexpanded cord blood units.
  • Miami, Florida
  • +8 more
Jun 25, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma Trial in Boston (GCSF, meloxicam, Placebo)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
May 15, 2020

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma Trial in Boston (drug, radiation, biological)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • +4 more
  • Boston, Massachusetts
  • +2 more
Dec 29, 2018

Non-Hodgkin's Lymphoma Trial in Boston, Omaha, New York (Bortezomib, CHOP, Rituximab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Bortezomib, CHOP, Rituximab
  • Boston, Massachusetts
  • +3 more
May 25, 2018

Non-Hodgkin's Lymphoma, CNS Lymphoma Trial in Boston (Autologous stem cell transplant, High-dose chemo)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • CNS Lymphoma
  • Autologous stem cell transplant
  • High-dose chemotherapy
  • Boston, Massachusetts
  • +1 more
Nov 27, 2017

Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Canada, United States (CAT-8015 (Moxetumomab Pasudotox))

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Non-Hodgkin's Lymphoma
  • CAT-8015 (Moxetumomab Pasudotox)
  • Los Angeles, California
  • +4 more
Aug 28, 2017

Procurement of Follicular B Cell Lymphoma Cells for Purpose of

Completed
  • Non-Hodgkin's Lymphoma
  • Procurement of Follicular B Cell Lymphoma Cells
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 8, 2017

Multiple Myeloma, Non-Hodgkin's Lymphoma, Hodgkin's Disease Trial in Boston (Tacrolimus, Sirolimus, G-CSF)

Completed
  • Multiple Myeloma
  • +4 more
  • Boston, Massachusetts
  • +1 more
Jul 22, 2016

AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)

Completed
  • AML
  • +8 more
  • Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jul 14, 2016

Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease Trial in United States

Completed
  • Lymphoblastic Leukemia, Acute, Childhood
  • +3 more
  • Los Angeles, California
  • +19 more
Nov 20, 2015

Cutaneous T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (belinostat)

Terminated
Has Results
  • Cutaneous T-Cell Lymphoma
  • +2 more
  • Stanford, California
  • +14 more
Jul 7, 2015

Non-Hodgkin's Lymphoma Trial in Australia, Canada, United States (bendamustine and rituximab)

Completed
  • Non-Hodgkin's Lymphoma
  • bendamustine and rituximab
  • Anchorage, Alaska
  • +33 more
May 8, 2014

Non-Hodgkin's Lymphoma Trial in Canada, Puerto Rico, United States (Bendamustine HCl)

Completed
  • Non-Hodgkin's Lymphoma
  • Bendamustine HCl
  • Birmingham, Alabama
  • +39 more
May 8, 2014

Non-Hodgkin's Lymphoma Trial in Canada, United States (SDX-105)

Completed
  • Non-Hodgkin's Lymphoma
  • Birmingham, Alabama
  • +16 more
May 8, 2014

Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in Czech Republic, Russian Federation, United

Terminated
  • Non-Hodgkin's Lymphoma
  • +2 more
  • San Francisco, California
  • +19 more
Jan 3, 2014

Non-Hodgkin's Lymphoma Trial in United States (IDEC-114)

Completed
  • Non-Hodgkin's Lymphoma
  • Birmingham, Alabama
  • +21 more
Sep 12, 2013

Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • VCL-CB01
  • Phosphate-buffered Saline (PBS)
  • Tucson, Arizona
  • +21 more
Jul 31, 2013

Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)

Completed
  • Hodgkin's Lymphoma
  • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jul 15, 2013

    Non-Hodgkin's Lymphoma Trial in Boston (bortezomib, Rituximab, Cyclophosphamide)

    Terminated
    • Non-Hodgkin's Lymphoma
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Nov 30, 2012

    Hematologic Malignancies, Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sirolimus, Tacrolimus)

    Completed
    • Hematologic Malignancies
    • +5 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 24, 2012